A Phase 3 Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study Comparing the Efficacy and Safety of SB206 and Vehicle Gel Once Daily in the Treatment of Molluscum Contagiosum
Status: Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 08 Oct 2019
Price : $35 *
At a glance
- Drugs Berdazimer sodium (Primary)
- Indications Molluscum contagiosum
- Focus Registrational; Therapeutic Use
- Acronyms B-SIMPLE2
- Sponsors Novan Inc
- 08 Oct 2019 According to a Novan Inc media release, topline results from the study are targeted no later than early in the first quarter of 2020.
- 09 Sep 2019 Status changed from recruiting to active, no longer recruiting.
- 03 Sep 2019 According to a Novan Inc media release, B-SIMPLE1 and B-SIMPLE2 could lead to a potential NDA submission.